Suppliers for CAS
128-13-2
|
Properties | CAS |
128-13-2 | Formula |
C24H40O4 | EINECS |
204-879-3 |
|
|
31 Registered suppliers
Simagchem Corporation
P.R.China
Aecochem Corp.
P.R.China
Dayang Chem (Hangzhou) Co.,Ltd.
P.R.China
Sancai Industry Co.,Ltd.
P.R.China
Appearance | White or almost white powder
| Solubility | Practically insoluble in water, freely soluble in ethanol (96 percent),slightly soluble in acetone, practically insoluble in methylene chloride
| Identification | Infrared absorption, TLC and chrominance test
| Melting point | About 202oC
| Specific optical rotation | [α ]D20; +58.0o~+62.0o
| Heavy metals | ≤ 20PPM
| Loss on drying | ≤ 1.0%
| Sulphated ash | ≤ 0.1%
| Residual solvents |
| Acetone | ≤ 0.5%
| Methanol | ≤ 0.3%
| Secondary Butyl Alcohol | ≤ 0.5%
| Assay (titration) | 99.0%~101.0%(on the dried basis)
| Related substance(TLC) |
| Lithocholic acid | ≤ 0.1%
| Cholic acid | ≤ 0.5%
| Chenodeoxycholic Acid | ≤ 1.0%
| Others | ≤ 0.25%
| Standard | EP grade
| Content | 99.0~101.0%
| Capacity | 10MT/month
| Loading port | Shanghai
| Use | Ursodeoxycholic acid, Used as an anticholelithogenic. Epimer with Chenodiol with respect to the hydroxyl group at C7.
| Package | 25kg/drum or according to the customers’ demand
| Storage | Stored in the dry and ventilated inside storeroom, prevent direct sunlight, slightly pile and put down |
H&Z Industry Co.,Ltd
P.R.China
Appearance | White or almost white powder
| Solubility | Practically insoluble in water, freely soluble in ethanol (96 percent),slightly soluble in acetone, practically insoluble in methylene chloride
| Identification | Infrared absorption, TLC and chrominance test
| Melting point | About 202oC
| Specific optical rotation | [α ]D20; +58.0o~+62.0o
| Heavy metals | ≤ 20PPM
| Loss on drying | ≤ 1.0%
| Sulphated ash | ≤ 0.1%
| Residual solvents |
| Acetone | ≤ 0.5%
| Methanol | ≤ 0.3%
| Secondary Butyl Alcohol | ≤ 0.5%
| Assay (titration) | 99.0%~101.0%(on the dried basis)
| Related substance(TLC) |
| Lithocholic acid | ≤ 0.1%
| Cholic acid | ≤ 0.5%
| Chenodeoxycholic Acid | ≤ 1.0%
| Others | ≤ 0.25%
| Standard | EP grade
| Content | 99.0~101.0%
| Capacity | 10MT/month
| Loading port | Shanghai
| Use | Ursodeoxycholic acid, Used as an anticholelithogenic. Epimer with Chenodiol with respect to the hydroxyl group at C7.
| Package | 25kg/drum or according to the customers’ demand
| Storage | Stored in the dry and ventilated inside storeroom, prevent direct sunlight, slightly pile and put down |
Xingrui Industry Co., Limited
P.R.China
Appearance | White or almost white powder
| Solubility | Practically insoluble in water, freely soluble in ethanol (96 percent),slightly soluble in acetone, practically insoluble in methylene chloride
| Identification | Infrared absorption, TLC and chrominance test
| Melting point | About 202oC
| Specific optical rotation | [α ]D20; +58.0o~+62.0o
| Heavy metals | ≤ 20PPM
| Loss on drying | ≤ 1.0%
| Sulphated ash | ≤ 0.1%
| Residual solvents |
| Acetone | ≤ 0.5%
| Methanol | ≤ 0.3%
| Secondary Butyl Alcohol | ≤ 0.5%
| Assay (titration) | 99.0%~101.0%(on the dried basis)
| Related substance(TLC) |
| Lithocholic acid | ≤ 0.1%
| Cholic acid | ≤ 0.5%
| Chenodeoxycholic Acid | ≤ 1.0%
| Others | ≤ 0.25%
| Standard | EP grade
| Content | 99.0~101.0%
| Capacity | 10MT/month
| Loading port | Shanghai
| Use | Ursodeoxycholic acid, Used as an anticholelithogenic. Epimer with Chenodiol with respect to the hydroxyl group at C7.
| Package | 25kg/drum or according to the customers’ demand
| Storage | Stored in the dry and ventilated inside storeroom, prevent direct sunlight, slightly pile and put down |
Hangzhou Meite Industry Co., Ltd (Hangzhou Meite Chemical Co., Ltd)
P.R.China
Appearance | White or almost white powder
| Solubility | Practically insoluble in water, freely soluble in ethanol (96 percent),slightly soluble in acetone, practically insoluble in methylene chloride
| Identification | Infrared absorption, TLC and chrominance test
| Melting point | About 202oC
| Specific optical rotation | [α ]D20; +58.0o~+62.0o
| Heavy metals | ≤ 20PPM
| Loss on drying | ≤ 1.0%
| Sulphated ash | ≤ 0.1%
| Residual solvents |
| Acetone | ≤ 0.5%
| Methanol | ≤ 0.3%
| Secondary Butyl Alcohol | ≤ 0.5%
| Assay (titration) | 99.0%~101.0%(on the dried basis)
| Related substance(TLC) |
| Lithocholic acid | ≤ 0.1%
| Cholic acid | ≤ 0.5%
| Chenodeoxycholic Acid | ≤ 1.0%
| Others | ≤ 0.25%
| Standard | EP grade
| Content | 99.0~101.0%
| Capacity | 10MT/month
| Loading port | Shanghai
| Use | Ursodeoxycholic acid, Used as an anticholelithogenic. Epimer with Chenodiol with respect to the hydroxyl group at C7.
| Package | 25kg/drum or according to the customers’ demand
| Storage | Stored in the dry and ventilated inside storeroom, prevent direct sunlight, slightly pile and put down |
Sigma-Aldrich International GmbH
Switzerland
Appearance | White or almost white powder
| Solubility | Practically insoluble in water, freely soluble in ethanol (96 percent),slightly soluble in acetone, practically insoluble in methylene chloride
| Identification | Infrared absorption, TLC and chrominance test
| Melting point | About 202oC
| Specific optical rotation | [α ]D20; +58.0o~+62.0o
| Heavy metals | ≤ 20PPM
| Loss on drying | ≤ 1.0%
| Sulphated ash | ≤ 0.1%
| Residual solvents |
| Acetone | ≤ 0.5%
| Methanol | ≤ 0.3%
| Secondary Butyl Alcohol | ≤ 0.5%
| Assay (titration) | 99.0%~101.0%(on the dried basis)
| Related substance(TLC) |
| Lithocholic acid | ≤ 0.1%
| Cholic acid | ≤ 0.5%
| Chenodeoxycholic Acid | ≤ 1.0%
| Others | ≤ 0.25%
| Standard | EP grade
| Content | 99.0~101.0%
| Capacity | 10MT/month
| Loading port | Shanghai
| Use | Ursodeoxycholic acid, Used as an anticholelithogenic. Epimer with Chenodiol with respect to the hydroxyl group at C7.
| Package | 25kg/drum or according to the customers’ demand
| Storage | Stored in the dry and ventilated inside storeroom, prevent direct sunlight, slightly pile and put down |
Yixing TRY New Materials Co.,Ltd.
P.R.China
Appearance :
White powder, odorless; Insoluble in water, easily soluble in 96% ethanol, slightly soluble in acetone, insoluble in dichloromethane.
Application :
Cholelithiolytic drugs. It is mainly used for cholesterol gallstones not suitable for surgical treatment, especially the gallbladder function is basically normal, stone diameter below 15mm, X-ray, non-calcified floating cholesterol stones with high cure rate. It also has certain therapeutic effect on toxic hepatitis, cholecystitis, primary sclerosing cholangitis and primary cholestatic cirrhosis. To improve the efficacy of α-interferon in the treatment of chronic hepatitis C. There are diarrhea, rare constipation, allergic reaction, itching, headache, dizziness, stomach pain, pancreatitis and bradycardia. Complete obstruction of biliary tract and severe liver dysfunction and
pregnant women should not use.
Chemvon Biotechnology Co. Ltd.
P.R.China
Appearance :
White powder, odorless; Insoluble in water, easily soluble in 96% ethanol, slightly soluble in acetone, insoluble in dichloromethane.
Application :
Cholelithiolytic drugs. It is mainly used for cholesterol gallstones not suitable for surgical treatment, especially the gallbladder function is basically normal, stone diameter below 15mm, X-ray, non-calcified floating cholesterol stones with high cure rate. It also has certain therapeutic effect on toxic hepatitis, cholecystitis, primary sclerosing cholangitis and primary cholestatic cirrhosis. To improve the efficacy of α-interferon in the treatment of chronic hepatitis C. There are diarrhea, rare constipation, allergic reaction, itching, headache, dizziness, stomach pain, pancreatitis and bradycardia. Complete obstruction of biliary tract and severe liver dysfunction and
pregnant women should not use.
Zouping Mingxing Chemical Co., Ltd.
P.R.China
Appearance :
White powder, odorless; Insoluble in water, easily soluble in 96% ethanol, slightly soluble in acetone, insoluble in dichloromethane.
Application :
Cholelithiolytic drugs. It is mainly used for cholesterol gallstones not suitable for surgical treatment, especially the gallbladder function is basically normal, stone diameter below 15mm, X-ray, non-calcified floating cholesterol stones with high cure rate. It also has certain therapeutic effect on toxic hepatitis, cholecystitis, primary sclerosing cholangitis and primary cholestatic cirrhosis. To improve the efficacy of α-interferon in the treatment of chronic hepatitis C. There are diarrhea, rare constipation, allergic reaction, itching, headache, dizziness, stomach pain, pancreatitis and bradycardia. Complete obstruction of biliary tract and severe liver dysfunction and
pregnant women should not use.
Xiamen Kinbester Co., Ltd.
P.R.China
Appearance :
White powder, odorless; Insoluble in water, easily soluble in 96% ethanol, slightly soluble in acetone, insoluble in dichloromethane.
Application :
Cholelithiolytic drugs. It is mainly used for cholesterol gallstones not suitable for surgical treatment, especially the gallbladder function is basically normal, stone diameter below 15mm, X-ray, non-calcified floating cholesterol stones with high cure rate. It also has certain therapeutic effect on toxic hepatitis, cholecystitis, primary sclerosing cholangitis and primary cholestatic cirrhosis. To improve the efficacy of α-interferon in the treatment of chronic hepatitis C. There are diarrhea, rare constipation, allergic reaction, itching, headache, dizziness, stomach pain, pancreatitis and bradycardia. Complete obstruction of biliary tract and severe liver dysfunction and
pregnant women should not use.
X´ian Taicheng Chem Co., Ltd
P.R.China
Appearance :
White powder, odorless; Insoluble in water, easily soluble in 96% ethanol, slightly soluble in acetone, insoluble in dichloromethane.
Application :
Cholelithiolytic drugs. It is mainly used for cholesterol gallstones not suitable for surgical treatment, especially the gallbladder function is basically normal, stone diameter below 15mm, X-ray, non-calcified floating cholesterol stones with high cure rate. It also has certain therapeutic effect on toxic hepatitis, cholecystitis, primary sclerosing cholangitis and primary cholestatic cirrhosis. To improve the efficacy of α-interferon in the treatment of chronic hepatitis C. There are diarrhea, rare constipation, allergic reaction, itching, headache, dizziness, stomach pain, pancreatitis and bradycardia. Complete obstruction of biliary tract and severe liver dysfunction and
pregnant women should not use.
Create Chemical Co., Ltd.
P.R.China
Molecular Fomula | C24H40O4
| Molecular weight | 392.57
| Appearance | white powder
| Assay | 99% |
JieJie Group Co., Ltd.
P.R.China
Molecular Fomula | C24H40O4
| Molecular weight | 392.57
| Appearance | white powder
| Assay | 99% |
Shandong Minglang Chemical Co., Ltd
P.R.China
Molecular Fomula | C24H40O4
| Molecular weight | 392.57
| Appearance | white powder
| Assay | 99% |
Hangzhou Zhongqi Chem Co., Ltd
P.R.China
Molecular Fomula | C24H40O4
| Molecular weight | 392.57
| Appearance | white powder
| Assay | 99% |
Nantong Xindao Biotech Ltd
P.R.China
Molecular Fomula | C24H40O4
| Molecular weight | 392.57
| Appearance | white powder
| Assay | 99% |
Lori Industry Co., Ltd
P.R.China
Molecular Fomula | C24H40O4
| Molecular weight | 392.57
| Appearance | white powder
| Assay | 99% |
Zehao Industry Co., Ltd.
P.R.China
Appearance | White or off-white powder
| Lithocholic acid | ≤ 0.1%
| Single Impurity | ≤ 0.1%
| Total Impurities | ≤ 1.5%
| Assay | 99.0 ~ 101.0% |
Finetech Industry Limited
P.R.China
More details are to be found here
Hangzhou Lingrui Chemical Co., Ltd.
P.R.China
More details are to be found here
Skyrun Industrial Co., Ltd.
P.R.China
More details are to be found here
BOC Sciences
USA
Description : Ursodeoxycholic acid (UDCS) is a cell protectant used extensively to mitigate hepatic and biliary diseases. Ursodeoxycholic acid may be used to study its specific activities that range from reduction of cholesterol absorpition, cholesterol gallstone dissolution to suppression of immune response.IC50: M1-family aminopeptidase: IC50 = 2.6 µM (Plasmodium falciparum 3D7); NTCP: IC50 = 3.6 µM (human); HCT-116: IC50 = > 50 µM (human); GBM: IC50 = > 50 µM (human) Asbt: Ki= 75 µM (human) - Molecular Weight :392.57
- Boiling Point :547.1°C
- Melting Point :203-204 °C (lit.)
- Purity :≥ 99.0%
Molecular Formula : C24H40O4 Canonical SMILES : CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C InChI : 1S/C24H40O4/c1-14(4-7-21(27)28)17-5-6-18-22-19(9-11-24(17,18)3)23(2)10-8-16(25)12-15(23)13-20(22)26/h14-20,22,25-26H,4-13H2,1-3H3,(H,27,28)/t14-,15+,16-,17-,18+,19+,20+,22+,23+,24-/m1/s1 InChIKey : RUDATBOHQWOJDD-UZVSRGJWSA-N Solubility : Soluble in Ethanol (50 mg/ml) Appearance : White Crystal Powder Application : Gallstone-dissolving drugs; Anti-neoplastic; For the prevention and treatment of cholesterol gallstones; Reduces hydrophobic bile acids and decreases both lymphocyte reactivity and serum alkaline phosphatase levels,IC50: M1-family aminopeptidase: IC50 = 2.6 µM (Plasmodium falciparum 3D7); NTCP: IC50 = 3.6 µM (human); HCT-116: IC50 = > 50 µM (human); GBM: IC50 = > 50 µM (human) Asbt: Ki= 75 µM (human) Storage : Store at RT Synonyms : 5beta-cholanic acid-3alpha,7beta-diol; Actigall; ursodeoxycholate; ursodiol; Ursodeoxycholic acid
More details are to be found here
Shandong SanYoung Industry Co., Ltd
P.R.China
Description : Ursodeoxycholic acid (UDCS) is a cell protectant used extensively to mitigate hepatic and biliary diseases. Ursodeoxycholic acid may be used to study its specific activities that range from reduction of cholesterol absorpition, cholesterol gallstone dissolution to suppression of immune response.IC50: M1-family aminopeptidase: IC50 = 2.6 µM (Plasmodium falciparum 3D7); NTCP: IC50 = 3.6 µM (human); HCT-116: IC50 = > 50 µM (human); GBM: IC50 = > 50 µM (human) Asbt: Ki= 75 µM (human) - Molecular Weight :392.57
- Boiling Point :547.1°C
- Melting Point :203-204 °C (lit.)
- Purity :≥ 99.0%
Molecular Formula : C24H40O4 Canonical SMILES : CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C InChI : 1S/C24H40O4/c1-14(4-7-21(27)28)17-5-6-18-22-19(9-11-24(17,18)3)23(2)10-8-16(25)12-15(23)13-20(22)26/h14-20,22,25-26H,4-13H2,1-3H3,(H,27,28)/t14-,15+,16-,17-,18+,19+,20+,22+,23+,24-/m1/s1 InChIKey : RUDATBOHQWOJDD-UZVSRGJWSA-N Solubility : Soluble in Ethanol (50 mg/ml) Appearance : White Crystal Powder Application : Gallstone-dissolving drugs; Anti-neoplastic; For the prevention and treatment of cholesterol gallstones; Reduces hydrophobic bile acids and decreases both lymphocyte reactivity and serum alkaline phosphatase levels,IC50: M1-family aminopeptidase: IC50 = 2.6 µM (Plasmodium falciparum 3D7); NTCP: IC50 = 3.6 µM (human); HCT-116: IC50 = > 50 µM (human); GBM: IC50 = > 50 µM (human) Asbt: Ki= 75 µM (human) Storage : Store at RT Synonyms : 5beta-cholanic acid-3alpha,7beta-diol; Actigall; ursodeoxycholate; ursodiol; Ursodeoxycholic acid
More details are to be found here
Carbone Scientific Co., Ltd.
U.K.
Description : Ursodeoxycholic acid (UDCS) is a cell protectant used extensively to mitigate hepatic and biliary diseases. Ursodeoxycholic acid may be used to study its specific activities that range from reduction of cholesterol absorpition, cholesterol gallstone dissolution to suppression of immune response.IC50: M1-family aminopeptidase: IC50 = 2.6 µM (Plasmodium falciparum 3D7); NTCP: IC50 = 3.6 µM (human); HCT-116: IC50 = > 50 µM (human); GBM: IC50 = > 50 µM (human) Asbt: Ki= 75 µM (human) - Molecular Weight :392.57
- Boiling Point :547.1°C
- Melting Point :203-204 °C (lit.)
- Purity :≥ 99.0%
Molecular Formula : C24H40O4 Canonical SMILES : CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C InChI : 1S/C24H40O4/c1-14(4-7-21(27)28)17-5-6-18-22-19(9-11-24(17,18)3)23(2)10-8-16(25)12-15(23)13-20(22)26/h14-20,22,25-26H,4-13H2,1-3H3,(H,27,28)/t14-,15+,16-,17-,18+,19+,20+,22+,23+,24-/m1/s1 InChIKey : RUDATBOHQWOJDD-UZVSRGJWSA-N Solubility : Soluble in Ethanol (50 mg/ml) Appearance : White Crystal Powder Application : Gallstone-dissolving drugs; Anti-neoplastic; For the prevention and treatment of cholesterol gallstones; Reduces hydrophobic bile acids and decreases both lymphocyte reactivity and serum alkaline phosphatase levels,IC50: M1-family aminopeptidase: IC50 = 2.6 µM (Plasmodium falciparum 3D7); NTCP: IC50 = 3.6 µM (human); HCT-116: IC50 = > 50 µM (human); GBM: IC50 = > 50 µM (human) Asbt: Ki= 75 µM (human) Storage : Store at RT Synonyms : 5beta-cholanic acid-3alpha,7beta-diol; Actigall; ursodeoxycholate; ursodiol; Ursodeoxycholic acid
More details are to be found here
Xiamen Equation Chemical Co.,Ltd
P.R.China
Description : Ursodeoxycholic acid (UDCS) is a cell protectant used extensively to mitigate hepatic and biliary diseases. Ursodeoxycholic acid may be used to study its specific activities that range from reduction of cholesterol absorpition, cholesterol gallstone dissolution to suppression of immune response.IC50: M1-family aminopeptidase: IC50 = 2.6 µM (Plasmodium falciparum 3D7); NTCP: IC50 = 3.6 µM (human); HCT-116: IC50 = > 50 µM (human); GBM: IC50 = > 50 µM (human) Asbt: Ki= 75 µM (human) - Molecular Weight :392.57
- Boiling Point :547.1°C
- Melting Point :203-204 °C (lit.)
- Purity :≥ 99.0%
Molecular Formula : C24H40O4 Canonical SMILES : CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C InChI : 1S/C24H40O4/c1-14(4-7-21(27)28)17-5-6-18-22-19(9-11-24(17,18)3)23(2)10-8-16(25)12-15(23)13-20(22)26/h14-20,22,25-26H,4-13H2,1-3H3,(H,27,28)/t14-,15+,16-,17-,18+,19+,20+,22+,23+,24-/m1/s1 InChIKey : RUDATBOHQWOJDD-UZVSRGJWSA-N Solubility : Soluble in Ethanol (50 mg/ml) Appearance : White Crystal Powder Application : Gallstone-dissolving drugs; Anti-neoplastic; For the prevention and treatment of cholesterol gallstones; Reduces hydrophobic bile acids and decreases both lymphocyte reactivity and serum alkaline phosphatase levels,IC50: M1-family aminopeptidase: IC50 = 2.6 µM (Plasmodium falciparum 3D7); NTCP: IC50 = 3.6 µM (human); HCT-116: IC50 = > 50 µM (human); GBM: IC50 = > 50 µM (human) Asbt: Ki= 75 µM (human) Storage : Store at RT Synonyms : 5beta-cholanic acid-3alpha,7beta-diol; Actigall; ursodeoxycholate; ursodiol; Ursodeoxycholic acid
More details are to be found here
AK Scientific, Inc.
USA
Description : Ursodeoxycholic acid (UDCS) is a cell protectant used extensively to mitigate hepatic and biliary diseases. Ursodeoxycholic acid may be used to study its specific activities that range from reduction of cholesterol absorpition, cholesterol gallstone dissolution to suppression of immune response.IC50: M1-family aminopeptidase: IC50 = 2.6 µM (Plasmodium falciparum 3D7); NTCP: IC50 = 3.6 µM (human); HCT-116: IC50 = > 50 µM (human); GBM: IC50 = > 50 µM (human) Asbt: Ki= 75 µM (human) - Molecular Weight :392.57
- Boiling Point :547.1°C
- Melting Point :203-204 °C (lit.)
- Purity :≥ 99.0%
Molecular Formula : C24H40O4 Canonical SMILES : CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C InChI : 1S/C24H40O4/c1-14(4-7-21(27)28)17-5-6-18-22-19(9-11-24(17,18)3)23(2)10-8-16(25)12-15(23)13-20(22)26/h14-20,22,25-26H,4-13H2,1-3H3,(H,27,28)/t14-,15+,16-,17-,18+,19+,20+,22+,23+,24-/m1/s1 InChIKey : RUDATBOHQWOJDD-UZVSRGJWSA-N Solubility : Soluble in Ethanol (50 mg/ml) Appearance : White Crystal Powder Application : Gallstone-dissolving drugs; Anti-neoplastic; For the prevention and treatment of cholesterol gallstones; Reduces hydrophobic bile acids and decreases both lymphocyte reactivity and serum alkaline phosphatase levels,IC50: M1-family aminopeptidase: IC50 = 2.6 µM (Plasmodium falciparum 3D7); NTCP: IC50 = 3.6 µM (human); HCT-116: IC50 = > 50 µM (human); GBM: IC50 = > 50 µM (human) Asbt: Ki= 75 µM (human) Storage : Store at RT Synonyms : 5beta-cholanic acid-3alpha,7beta-diol; Actigall; ursodeoxycholate; ursodiol; Ursodeoxycholic acid
More details are to be found here
Chemos GmbH & Co. KG
Germany
Description : Ursodeoxycholic acid (UDCS) is a cell protectant used extensively to mitigate hepatic and biliary diseases. Ursodeoxycholic acid may be used to study its specific activities that range from reduction of cholesterol absorpition, cholesterol gallstone dissolution to suppression of immune response.IC50: M1-family aminopeptidase: IC50 = 2.6 µM (Plasmodium falciparum 3D7); NTCP: IC50 = 3.6 µM (human); HCT-116: IC50 = > 50 µM (human); GBM: IC50 = > 50 µM (human) Asbt: Ki= 75 µM (human) - Molecular Weight :392.57
- Boiling Point :547.1°C
- Melting Point :203-204 °C (lit.)
- Purity :≥ 99.0%
Molecular Formula : C24H40O4 Canonical SMILES : CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C InChI : 1S/C24H40O4/c1-14(4-7-21(27)28)17-5-6-18-22-19(9-11-24(17,18)3)23(2)10-8-16(25)12-15(23)13-20(22)26/h14-20,22,25-26H,4-13H2,1-3H3,(H,27,28)/t14-,15+,16-,17-,18+,19+,20+,22+,23+,24-/m1/s1 InChIKey : RUDATBOHQWOJDD-UZVSRGJWSA-N Solubility : Soluble in Ethanol (50 mg/ml) Appearance : White Crystal Powder Application : Gallstone-dissolving drugs; Anti-neoplastic; For the prevention and treatment of cholesterol gallstones; Reduces hydrophobic bile acids and decreases both lymphocyte reactivity and serum alkaline phosphatase levels,IC50: M1-family aminopeptidase: IC50 = 2.6 µM (Plasmodium falciparum 3D7); NTCP: IC50 = 3.6 µM (human); HCT-116: IC50 = > 50 µM (human); GBM: IC50 = > 50 µM (human) Asbt: Ki= 75 µM (human) Storage : Store at RT Synonyms : 5beta-cholanic acid-3alpha,7beta-diol; Actigall; ursodeoxycholate; ursodiol; Ursodeoxycholic acid
More details are to be found here
BuGuCh & Partners
Germany
Description : Ursodeoxycholic acid (UDCS) is a cell protectant used extensively to mitigate hepatic and biliary diseases. Ursodeoxycholic acid may be used to study its specific activities that range from reduction of cholesterol absorpition, cholesterol gallstone dissolution to suppression of immune response.IC50: M1-family aminopeptidase: IC50 = 2.6 µM (Plasmodium falciparum 3D7); NTCP: IC50 = 3.6 µM (human); HCT-116: IC50 = > 50 µM (human); GBM: IC50 = > 50 µM (human) Asbt: Ki= 75 µM (human) - Molecular Weight :392.57
- Boiling Point :547.1°C
- Melting Point :203-204 °C (lit.)
- Purity :≥ 99.0%
Molecular Formula : C24H40O4 Canonical SMILES : CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C InChI : 1S/C24H40O4/c1-14(4-7-21(27)28)17-5-6-18-22-19(9-11-24(17,18)3)23(2)10-8-16(25)12-15(23)13-20(22)26/h14-20,22,25-26H,4-13H2,1-3H3,(H,27,28)/t14-,15+,16-,17-,18+,19+,20+,22+,23+,24-/m1/s1 InChIKey : RUDATBOHQWOJDD-UZVSRGJWSA-N Solubility : Soluble in Ethanol (50 mg/ml) Appearance : White Crystal Powder Application : Gallstone-dissolving drugs; Anti-neoplastic; For the prevention and treatment of cholesterol gallstones; Reduces hydrophobic bile acids and decreases both lymphocyte reactivity and serum alkaline phosphatase levels,IC50: M1-family aminopeptidase: IC50 = 2.6 µM (Plasmodium falciparum 3D7); NTCP: IC50 = 3.6 µM (human); HCT-116: IC50 = > 50 µM (human); GBM: IC50 = > 50 µM (human) Asbt: Ki= 75 µM (human) Storage : Store at RT Synonyms : 5beta-cholanic acid-3alpha,7beta-diol; Actigall; ursodeoxycholate; ursodiol; Ursodeoxycholic acid
More details are to be found here
Santa Cruz Biotechnology, Inc.
USA
Description : Ursodeoxycholic acid (UDCS) is a cell protectant used extensively to mitigate hepatic and biliary diseases. Ursodeoxycholic acid may be used to study its specific activities that range from reduction of cholesterol absorpition, cholesterol gallstone dissolution to suppression of immune response.IC50: M1-family aminopeptidase: IC50 = 2.6 µM (Plasmodium falciparum 3D7); NTCP: IC50 = 3.6 µM (human); HCT-116: IC50 = > 50 µM (human); GBM: IC50 = > 50 µM (human) Asbt: Ki= 75 µM (human) - Molecular Weight :392.57
- Boiling Point :547.1°C
- Melting Point :203-204 °C (lit.)
- Purity :≥ 99.0%
Molecular Formula : C24H40O4 Canonical SMILES : CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C InChI : 1S/C24H40O4/c1-14(4-7-21(27)28)17-5-6-18-22-19(9-11-24(17,18)3)23(2)10-8-16(25)12-15(23)13-20(22)26/h14-20,22,25-26H,4-13H2,1-3H3,(H,27,28)/t14-,15+,16-,17-,18+,19+,20+,22+,23+,24-/m1/s1 InChIKey : RUDATBOHQWOJDD-UZVSRGJWSA-N Solubility : Soluble in Ethanol (50 mg/ml) Appearance : White Crystal Powder Application : Gallstone-dissolving drugs; Anti-neoplastic; For the prevention and treatment of cholesterol gallstones; Reduces hydrophobic bile acids and decreases both lymphocyte reactivity and serum alkaline phosphatase levels,IC50: M1-family aminopeptidase: IC50 = 2.6 µM (Plasmodium falciparum 3D7); NTCP: IC50 = 3.6 µM (human); HCT-116: IC50 = > 50 µM (human); GBM: IC50 = > 50 µM (human) Asbt: Ki= 75 µM (human) Storage : Store at RT Synonyms : 5beta-cholanic acid-3alpha,7beta-diol; Actigall; ursodeoxycholate; ursodiol; Ursodeoxycholic acid
More details are to be found here
Detailed information on the suppliers of
|